| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/06/2009 | CA2295446C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 01/06/2009 | CA2227851C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 01/06/2009 | CA2216546C 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity |
| 01/02/2009 | DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 01/01/2009 | US20090005574 reacting a 9-hydroxymethyl-2-amino fluorene with a silyl protecting reagent e.g. tert-butyldimethylsilyl chloride to form tert-butyldimethylsiloxy-9-methyl-2-aminofluorene, reacting intermediate with 3-maleimidopropionic acid; protecting; chemical intermediates for protein and peptide drugs |
| 01/01/2009 | US20090005546 Azo compound and method of preparing the azo compound |
| 01/01/2009 | US20090005428 Imidazole Derivatives for the Treatment of Gastrointestinal Disorders |
| 01/01/2009 | US20090005403 Alkinyl-Oxypyrimidines Used in the Form of Pesticides |
| 01/01/2009 | US20090005399 Substituted Imidazo[2,1-b]thiazole Compounds and Uses Thereof |
| 01/01/2009 | US20090005394 Endothelin receptor antagonists |
| 01/01/2009 | US20090005393 Pyridine and Pyrimidine Derivatives as Inhibitors of Histone Deacetylase |
| 01/01/2009 | US20090005383 Thyroid hormone analogs |
| 01/01/2009 | US20090005364 Azole Derivatives With Antimuscarinic Activity |
| 01/01/2009 | US20090005363 Organic Compounds |
| 01/01/2009 | US20090005353 used in treating and/or preventing cardiovascular disorders, inflammatory diseases, Alzheimer's disease, dyslipidemia and metabolic syndrome |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090004185 Amino-substituted quinazoline derivatives as inhibitors of beta-catenin/tcf-4 pathway and cancer treatment agents |
| 12/31/2008 | WO2009003009A1 Substituted pyrrolidine as anti-infectives |
| 12/31/2008 | WO2009003003A2 Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues |
| 12/31/2008 | WO2009002806A1 Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer |
| 12/31/2008 | WO2009002469A1 Phthalazine compounds, compositions and methods of use |
| 12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
| 12/31/2008 | WO2009001132A1 Pyrazinone derivatives and their use in the treatment of lung diseases |
| 12/31/2008 | WO2009001127A1 Cyanocyclopropylcarboxamides as cathepsin inhibitors |
| 12/31/2008 | WO2009000757A1 Piperazine compounds with herbicidal action |
| 12/31/2008 | WO2009000753A1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres |
| 12/31/2008 | WO2009000533A1 Novel herbicides |
| 12/31/2008 | WO2008053221A3 Process for preparing indol- 5 -oxy- quinazoline derivatives and intermediates |
| 12/31/2008 | WO2008040995A9 Indazoles for use as dpp-iv inhibitors |
| 12/31/2008 | WO2008014381A3 Modulators of chemokine receptor activity, crystalline forms and process |
| 12/31/2008 | WO2008014360A3 Modulators of chemokine receptor activity, crystalline forms and process |
| 12/31/2008 | WO2006078753B1 N-substituted heterocyclic sulfonamides |
| 12/31/2008 | WO2006078753A4 N-substituted heterocyclic sulfonamides |
| 12/31/2008 | WO2005066173A3 Processes for the preparation of substituted azetidinone |
| 12/31/2008 | EP2009009A1 Crystalline antifungal compounds |
| 12/31/2008 | EP2008997A1 Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative |
| 12/31/2008 | EP2007789A2 Hcv/hiv inhibitors and their uses |
| 12/31/2008 | EP2007754A1 2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer |
| 12/31/2008 | EP2007753A1 Heterocyclic gaba alpha subtype selective receptor modulators |
| 12/31/2008 | EP2007752A2 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor |
| 12/31/2008 | EP2007751A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors |
| 12/31/2008 | EP2007750A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors |
| 12/31/2008 | EP2007749A2 Tetralines antagonists of the h-3 receptor |
| 12/31/2008 | EP2007747A1 Process for preparing heterocyclic derivatives |
| 12/31/2008 | EP2007745A2 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 12/31/2008 | EP2007735A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists |
| 12/31/2008 | EP2007734A1 Enzyme inhibitors |
| 12/31/2008 | EP2007729A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments |
| 12/31/2008 | EP1727812B1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
| 12/31/2008 | EP1680415B1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 12/31/2008 | EP1654254A4 Antifungal azole derivatives having a fluorovinyl moiety and process for the preparation thereof |
| 12/31/2008 | EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 12/31/2008 | EP1507775B1 Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| 12/31/2008 | EP1309587B1 Cinnoline compounds |
| 12/31/2008 | EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound |
| 12/31/2008 | CN101333215A Method for synthesizing sunitinib alkali |
| 12/31/2008 | CN101333214A Method for synthesizing perfluoroalkylated benzo [4,5] glyoxalino [1,2-alpha]miazine derivates |
| 12/31/2008 | CN101333196A 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
| 12/31/2008 | CN101333192A Biaryl substituted pyrazoles as sodium channel blockers |
| 12/31/2008 | CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 12/31/2008 | CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 12/31/2008 | CA2691932A1 Use of compounds for preparing anti-tuberculosis agents |
| 12/31/2008 | CA2691215A1 Pyrazinone derivatives and their use in the treatment of lung diseases |
| 12/31/2008 | CA2690799A1 Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer |
| 12/31/2008 | CA2690748A1 Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues |
| 12/31/2008 | CA2690378A1 Phthalazine compounds, compositions and methods of use |
| 12/31/2008 | CA2690176A1 Novel herbicides |
| 12/31/2008 | CA2686224A1 Piperazine compounds having herbicidal action |
| 12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 12/30/2008 | US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions |
| 12/30/2008 | US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response |
| 12/30/2008 | US7470702 Benzimidazoles |
| 12/30/2008 | US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 12/30/2008 | US7470699 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 12/30/2008 | US7470692 e.g. 4-[2-(5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenylcarbamoyl)-1-methyl-1H-indole-7-carbonyl]-piperazine-1-carboxylic acid ethyl ester; antiinflammatory, antidiabetic, analgesic agent; osteoarthritis, atherosclerosis, contact dermatitis, bone resorption diseases, reperfusion injury, asthma |
| 12/30/2008 | US7470689 6-chloro-4-(3H-imidazo[4,5-c]pyridin-2-yl)-2H-pyridazin-3-one and and 4-(3H-imidazol [4,5-c]pyridin-2-yl)-6-pyridin-4-yl-2H-pyridazin-3-one; cyclin-dependent kinase inhibitor; anticarcinogenic, antitumor agent |
| 12/30/2008 | US7470687 Aryl oximes |
| 12/30/2008 | US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres |
| 12/30/2008 | US7470685 e.g. 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one; control interleukin production; antiinflammatory, antidiabetic agent; interleukin IL-12 overproduction-related disorder: rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis |
| 12/30/2008 | US7470681 Pyrimidine compounds |
| 12/30/2008 | CA2441771C Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists i |
| 12/30/2008 | CA2429850C Ep4 receptor selective agonists in the treatment of osteoporosis |
| 12/30/2008 | CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 12/30/2008 | CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/30/2008 | CA2226256C New thrombin inhibitors, their preparation and use |
| 12/25/2008 | US20080319202 Fluid storage and dispensing methods and apparatus |
| 12/25/2008 | US20080319188 Novel pyridine derivatives and pyrimidine derivatives (3) |
| 12/25/2008 | US20080319046 Substituted sulfonamide-indoles |
| 12/25/2008 | US20080319005 Phenylacetamides Suitable as Protein Kinase Inhibitors |
| 12/25/2008 | US20080318987 Methods for modulating bone formation and mineralization |
| 12/25/2008 | US20080318984 Compounds Having Activity in Correcting Mutant-Cftr Processing and Uses Thereof |
| 12/25/2008 | US20080318977 Condensed Pyridines as Kinase Inhibitors |
| 12/25/2008 | US20080318975 Prevent transplant rejection |
| 12/25/2008 | US20080318973 Urotensin II receptor antagonists |
| 12/25/2008 | US20080318968 Chemical Compounds |
| 12/25/2008 | US20080318965 Derivatives of Alpha2-Adrenergic Receptor Agonist |
| 12/25/2008 | US20080318963 1-[6,7-Substituted Alkoxyquinoxalinyl) Aminocarbonyl]-4-(Hetero) Arylpiperazine Derivatives |
| 12/25/2008 | US20080318951 Dual-acting benzoimidazole antihypertensive agents |
| 12/25/2008 | US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 12/25/2008 | US20080318941 4' substituted compounds having 5-ht6 receptor affinity |